Complete a legally valid prescription.

Slides:



Advertisements
Similar presentations
Opioid Update F ederation of S tate M edical B oards Model Policy on the Use of Opioid Analgesics in the Treatment of Chronic Pain July 2013 F ederation.
Advertisements

The purpose is not to imply everyone on controlled substances will become addicted!!! Everyone on controlled substances is, however, at increased risk.
Chronic Pain Management Elaine Wendt, MD. Pain is now “Fifth Vital Sign”
Drug Utilization Review (DUR)
Best Practices Prescribing & Preventing Drug Diversion What All Nurses Must Know.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November-December 2007.
Using the Maine PMP to Improve Prescribing Practices for Potentially Addictive Prescription Medications Susan Payne, MPH, PhD Research Professor Institute.
Revised Informed Consent policy: What’s new?
Slide 1 Best Practices Working Group Chapter 244 Acts of 2012 Joint Policy Working Group Bureau of Health Care Safety and Quality Director Madeleine Biondolillo,
Opioid Use in Work-related Injuries Pacific Northwest Chapter - Association of Occupational Health Professionals (AOHP) January 4, 2011 Jaymie Mai, PharmD.
Youth program Presenters Name Date. Youth program Prescription for Danger The stats, myths, and risks of prescription drug abuse.
Prescription Drug Abuse Aka Oxy, Cotton, Prescription drug abuse means taking a prescription medication that is not prescribed for you or taking.
Texas State Board of Medical Examiners Bruce A. Levy, M.D., J.D.
Study Finds Persons Who Fill Buprenorphine Prescriptions Have Higher Rates of Medical Conditions Associated with Pain and Comorbid Psychiatric Disorders.
Prevention, Identification and Treatment of Opioid Use Disorders: A Personal Perspective Leah Bauer, MD Medical Director, Addiction Resource Center, Mid.
4/2000Copyright 2000 Scott Hainz, D.C> NATIONAL COMMITTEE FOR QUALITY ASSURANCE Guidelines for Medical Record Review.
Table of Contents.  Legal and Safety Issues Go Go  Prescriptions and Abbreviations Go Go.
TNSAM Addiction Medicine. Data source: Tennessee Department of Health, Office of Health Statistics, Death Statistical System. Overdose deaths were defined.
Implementing a Urine Drug Screening Protocol to Teach Appropriate Opioid Prescribing in a Residency Practice STFM Annual Conference May 2, 2016 Nata Young,
Medical Drugs, Intoxication Substances, and Somatic Diseases Evgeniya Koshkina Deputy Director for Science Moscow Research and Practical Centre on Addictions.
Chronic Pain Management Harald Lausen, DO, MA FCM Clerkship SIU School of Medicine.
SOONERCARE PAIN MANAGEMENT PROGRAM. SOONERCARE PAIN MANAGEMENT PROGRAM The SoonerCare Pain Management Program is designed to equip SoonerCare providers.
Safe Prescribing of Opioids for the Management of Chronic Nonterminal Pain La Tanya Austin, PGY3.
Sarah Thompson, PharmD, CDOE Director of Clinical Services, Coastal Medical.
One Care of SWVA A Consortium of Substance Abuse Coalitions Sarah T. Melton, PharmD,BCACP,BCPP, FASCP Chair, One Care
A System to Manage Long Term Opioid Prescribing in the Primary Care Setting Joy Nassar, MD University Medicine Foundation November 16, 2015.
© 2016 McGraw-Hill Education. All rights reserved. Ch 7 Medical Records and Informed Consent.
Prepared by Dr. Ramin Safakish, MD, FRCPC – March 2016.
ABC-MAP Act 191 of 2014 September 16, 2016 Pennsylvania’s Prescription Drug Monitoring Program (PA PDMP)
Incidental Medical Services (IMS) Department of
Maryland Prescription Drug Monitoring Program (PDMP)
clinical standards for health care information
How big is the problem? The Centers for Disease Control and Prevention (CDC) classifies prescription drug abuse as the fastest growing drug issue and epidemic.
The Role of Dentists in Preventing Opioid Abuse
Larry Halverson, MD Gabrielle Curtis, MD Cox FMR Springfield MO
Drugs and Prescription Records
Drugs and Prescription Records
THE OPIOID CRISIS Mississippi Board of Nursing
Medication-Assisted Therapy at Coleman Profession Services
MWCC.MS.GOV  Services  Medical Fee Schedule
Place name sticker or stamp with card
NOMA 2017 ETHICS AND OPIOIDS
Case Presentations.
STOP! Safe Treatment of Pain
OPIOID SAFETY. Indiana Statistics In Summary… About 100 Hoosiers die from drug overdoses every month, many from opioids such as heroin and prescription.
Know the facts: Series II
Opioid Prescribing & Monitoring
Weldon (Don) Havins, MD, JD, LLM (Health Law)
Weldon (Don) Havins, MD, JD, LLM (Health Law)
Confidential Records and Protected Disclosures
Weldon (Don) Havins, MD, JD, LLM (Health Law)
Controlled substance compliance
Medication order entry & Fill process
Differentiating Drug-Seeking Behavior From Poorly Controlled Pain
Barbara Allison-Bryan, MD
2017 Opioid Prescriber Survey Preliminary Results
Review why we’re doing this work Display survey results
Assessing Opioid Use Disorder, part 1
Prescription Drug Monitoring Program
Prescription Drug Monitoring Program
National Credentialing Forum 2019 San Diego, CA February
Dr. Wilfried Kunstmann - German Medical Association - Berlin
S. Paul Edwards, General Counsel
Opioid prescribing workflow in the electronic medical record.
Controlled Substances (CS) New Mandates, including use of CS in Treating Pain AB 474 – effective Jan. 1, 2018 Weldon (Don) Havins, MD, JD, LLM (Health.
Ch 18: Pharmacy.
Pain Management JEFFREY TAN HO, D.O.
Presentation transcript:

Complete a legally valid prescription. Flow Chart for the Initial Prescribing Controlled Substances under AB474 No, AB474 does not apply, prescribe according to standard of care. Are you prescribing a controlled substance? No No Start Here Yes Check PMP: Does your patient have a prescription for the same diagnosis over the same period of time? Evaluate risk factors. Incomplete Done Yes No Is the prescription for pain? Complete a legally valid prescription. Include: Patient’s date of birth ICD-10 diagnosis Minimum number of days for patient consumption Prescriber’s legible name and DEA number. Ready to prescribe? Yes Yes END Here Establish BONA FIDE provider-patient relationship Do NOT prescribe Incomplete Done Incomplete Establish preliminary diagnosis and treatment plan Done Done Identify patient-specific limitations. Incomplete Incomplete Incomplete Consider alternatives to controlled substances and document in Medical Record. For acute pain: 14-day maximum For opiate naive: No more than 90 MME For 30-Days or more: Complete a Prescription Medication Agreement Evaluate HERR: Medical History Physical Examination Obtain Medical Records Risks of Abuse Document in Medical Record good faith effort to obtain records. Obtain Informed Consent in writing. Done Done Done Risk Factors include: PT reluctant to reduce/stop RX PT using RX inappropriately PT change in physical health PT suspected of diverting RX PT chronic use opioids, abuse, misuse, illegal drug use, diversion suspected PMP indicates irregular behavior Irregular blood or urine screen PT not cooperative with exam, analysis, or text Test negative for drugs that should be there. PT increased dosage without Dr. authorization. Current RX ineffective PT using drugs/alcohol # of PT requests refills # of PT claims RX lost/stolen PT aberrant behavior/intoxication Prescription Medication Agreement must include: Goals of treatment Consent to testing to monitor use Requirement that CS is only taken as prescribed Prohibition on sharing Requirement that PT informs Dr. of: Other CS prescribed/taken Use of alcohol &/or cannabinoids Previous treatment for side effects/complications related to use of CS Each state previously resided in or had CS Rx filled Authorization for Dr. to conduct random inventory of CS Reasons Dr. may change/discontinue CS treatment Any other requirements determined by Dr. Informed Consent must contain: Potential risks & benefits of CS treatment (including risks & benefits of a form of the CS that is designed to deter abuse, if available) Proper use of CS Alternative treatments & cause of symptoms Provisions of the treatment plan Risks of dependence, addiction, overdose during treatment Methods to safely store & legally dispose of CS How refill requests will be addressed Risks to fetus (women 15-45) & availability of antagonist If a minor, the risks of abuse/misuse & ways to detect CS: Controlled Substance PT: Patient RX: Prescription Dr.: Practitioner KEY